Systemic mast cell disease with gastrointestinal symptoms - A diagnostic questionnaire;Die systemische mastzellerkrankung mit gastrointestinal betonter symptomatik - Eine checkliste als diagnoseinstrument

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 38, 2006, Pages 2095-2100

  Molderings, Gerhard J ^a   Kolck, U ^b   Scheurlen, C ^b   Bruss M ^a   Frieling, T ^c   Raithel, M ^d   Homann, J ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Evangelische Kliniken Bonn gGmbH   (Germany)

^c Medizinische Klinik II   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Diagnostic questionnaire; Mast cell mediators; Systemic mast cell disease

Indexed keywords

ALPHA INTERFERON; CYCLOSPORIN; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTEIN TYROSINE KINASE;

ANUS PRURITUS; CELL POPULATION; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; FATIGUE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SECRETION; GASTROINTESTINAL SYMPTOM; HUMAN; MAST CELL; MICROSCOPIC COLITIS; MUTATION; QUESTIONNAIRE; REVIEW; SUPRAVENTRICULAR TACHYCARDIA;

DIAGNOSIS, DIFFERENTIAL; ENDOCRINE SYSTEM DISEASES; GASTROINTESTINAL DISEASES; HUMANS; IMMUNE SYSTEM DISEASES; MASTOCYTOSIS; NEOPLASMS;

EID: 33749625886     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-951337     Document Type: Review

References (37)

1. Adler SN, Klein RA, Lyon DT. Bleeding after liver biopsy in a patient with systemic mastocytosis and malabsorption. J Clin Gastroenterol 1985; 7: 350-353
2. Akin C. Clonality and molecular pathogenesis of mastocytosis. Acta haematol 2005; 114: 61-69
3. Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702
4. Crivellato E, Beltrami CA, Mallardi F, Ribatti D. The mast cell: an active participant or an innocent bystander? Histol Histopathol 2004; 19: 259-270
5. Delling G, Ritzel H, Werner M. Histologische Charakteristika und Häufigkeit der sekundären Osteoporose bei systemischer Mastozytose. Pathologie 2001; 22: 132-140
6. G Escribano L, Akin C. Castells M, Schwartz LB. Current options in the treatment of mast cell mediator-related symptoms in mastocytosis. Inflamm Allergy Drug Targets 2006; 5: 61-77
7. Florian S, Kraurh MT, Simonitsch-Klupp I et al. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Int Arch Allergy Immunol 2005; 136: 273-280
8. Frieling T, Cooke HJ, Wood JD. Neuroimmune communication in the submucous plexus of guinea pig colon after sensitization to milk antigen. Am J Physiol 1994; 267: G1087-G1093
9. Frieling T, Palmer JM, Cooke HJ, Wood JD. Neuroimmune communication in the submucous plexus of guinea pig colon after infection with Trichinella spiralis. Gastroenterology 1994; 107: 1602-1609
10. Frungieri MB, Weidinger S, Meineke V, Köhn FM, Mayerhofer A. Proliferative action of mast cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPAR-gamma: Possible relevance to human fibrotic disorders. PNAS 2002; 99: 15072-15077
11. Henz BM, Maurer M, Lippert U, Worm M, Babina M. Mast cells as initiators of immunity and host defense. Exp Dermatol 2001; 10: 1-10
12. Horan RF, Austen KF. Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital. J Invest Dermatol 1991; 96: 5S-14S
13. Horny HP, Sotlar K, Sperr W, Valent P. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol 2004; 57: 604-608
14. Jensen RT. Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematology/Oncology Clinics North America 2000; 14: 579-623
15. Jordan JH, Jager E, Sperr WR et al. Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders. Eur Clin Invest 2003; 33: 611-618
16. Lange U, Teichmann J, Strunk J. Systemische Mastozytose als Ursache einer Osteoporose. Akt Rheumatol 2003; 28: 108-112
17. Maslinska D, Laure-Kaminiowska M, Gujski M, Ciurzynska G, Wojtecka-Lukasik E. Post- infectional distribution and phenotype of mast cells penetrating human brains. Inflamm Res 2005(Suppl 154: 15-16
18. McKay DM, Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunology today 1994; 15: 533-538
19. Michel K, Zeller F, Langer R et al. Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors. Gastroenterology 2005; 128: 1317-1326
20. Molderings GJ. Physiologische und therapeutische Bedeutung von Serotonin und des serotoninergen Systems. Arzneim-Forsch/Drug Res 2002; 52: 145-154
21. Molderings GJ, Homann J, Brüss M. Episodische gastrointestinale Beschwerden als Facette der systemischen Mastozytose - Kasuistik und neue Nachweismethode. Med Welt 2002; 53: 255-260
22. Molderings GJ, Brüss M, Raithel M et al. Systemische Mastozytose als Grund für chronische gastrointestinale Beschwerden. Dtsch Arztebl 2005; 102: A1744-A1749
23. Park CH, Joo YE, Choi SK, Rew JS, Kim SJ, Lee MC. Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominant irritabale bowel syndrome. J Korean Med Sci 2003; 18: 204-210
24. Parker RI. Hematologic aspects of systemic mastocytosis. Mast Cell Disorders 2000; 14: 557-568
25. Rohr SM, Rich MW, Silver KH. Shortness of breath, syncope, and cardiac arrest caused by systemic mastocytosis. Ann Emerg Med 2005; 45: 592-594
26. Rottem M, Mekori YA. Mast cells autoimmunity. Autoimmunity Rev 2005; 4: 21-27
27. Schemann M, Michel K, Ceregrzyn M, Zeller F, Seidl S, Bischoff SC. Human mast cell mediator cocktail excites neurons in human and guinea-pig enteric nervous system. Neurogastroenterol Motil 2005; 17: 281-289
28. Shibao C, Arzubiaga C, Roberts LJ et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension 2005; 45: 385-390
29. Silver RB, Reid AC, Mackins CJ et al. Mast cells: a unique source of renin. PNAS 2004; 101: 13607-13612
30. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003; 124: 1662-1671
31. Theoharides TC. The mast cell: a neuroimmunoendocrine master player. Int J Tiss Reac 1996; XVIII: 1-21
32. Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A. The role of mast cells in migraine pathophysiology. Brain Res Rev 2005; 49: 65-76
33. Thienemann F, Henz BM, Babina M. Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature cell lines versus mature human skin mast cells. Arch Dermatol Res 2004; 296: 134-138
34. Valabhij J, Robinson S, Johnson D, Mellamy M, Davies W, Bain BJ. Unexpected loss of consciousness: systemic mastocytosis. J Royal Soc Med 2000; 93: 141-142
35. Valent P, Akin C, Sperr WR et al. Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 2003; 122: 695-717
36. Vliagoftis H, Befus AD. Rapidly changing perspectives about mast cells at mucosal surfaces. Immunol Rev 2005; 206: 190-203
37. Xu X, Rivkind A, Pappo O, Pikarsky A, Levi-Schaffer F. Role of mast cells and myofibroblasts in human peritoneal adhesion formation. Ann Surg 2002; 236: 593-601